Aquestive Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
November 25 2020 - 9:15AM
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical
company focused on developing and commercializing differentiated
products that address patients’ unmet needs and solve therapeutic
problems, announced today that the management team will participate
in a fireside chat at the Piper Sandler Virtual 32nd Annual
Healthcare Conference to be held December 1-3, 2020. Aquestive will
host one-on-one investor meetings on December 2, 2020.
A webcast of the fireside chat will be available
on the "Events and Presentation" page of the Investors section of
the Company's website. A replay of webcast will be available for 30
days following the event. For more information, please visit
investors.aquestive.com.
About
Aquestive TherapeuticsAquestive
Therapeutics is a pharmaceutical company that applies innovative
technology to solve therapeutic problems and improve medicines for
patients. The Company has commercialized one internally-developed
proprietary product to date, Sympazan, has a commercial proprietary
product pipeline focused on the treatment of diseases of the
central nervous system, or CNS, and other unmet needs, and is
developing orally administered complex molecules to provide
alternatives to invasively administered standard of care therapies.
The Company also collaborates with other pharmaceutical companies
to bring new molecules to market using proprietary, best-in-class
technologies, like PharmFilm®, and has proven capabilities for drug
development and commercialization.
Investor inquiries:Stephanie
Carringtonstephanie.carrington@westwicke.com646-277-1282
Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Sep 2023 to Sep 2024